Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hospital Admission
100%
Symptom Trajectories
100%
Prospective Cohort Study
100%
Cognitive Symptoms
100%
COVID-19
100%
Longitudinal Prospective Cohort
100%
Subjective Cognitive Decline
81%
Occupational Change
45%
Rehospitalization
36%
Anxiety-depressive Disorders
36%
Illness
27%
Cognitive Deficits
27%
New Symptoms
27%
Odds Ratio
18%
National Institutes of Health
18%
Healthcare Research
18%
Cognitive Domains
18%
Cognitive Score
18%
Early Aspects
18%
Functional Impact
9%
Cognitive Recovery
9%
Cognitive Task
9%
Psychosocial Outcomes
9%
Change of Measure
9%
Mental Health Research
9%
Effective Strategies
9%
Oxford
9%
Poor Health
9%
C-reactive Protein
9%
Clinical Diagnosis
9%
Hospitalization
9%
Disease Stage
9%
Absolute Risk
9%
Acute Phase
9%
Patient Health Questionnaire
9%
Late-onset
9%
Sociodemographic Characteristics
9%
Cognitive Decline
9%
Economic Impact
9%
Early Management
9%
Early Identification
9%
Clinical Scales
9%
Severe Depression
9%
Assessment Scale
9%
Biomedical Research Centres
9%
Complex Syndrome
9%
D-dimer
9%
Occupational Functioning
9%
Cognitive Outcome
9%
Long-term Symptoms
9%
Occupational Status
9%
Cognitive Change
9%
Mild Depression
9%
Work Status
9%
Fatigue Scale
9%
Functional Assessment of Chronic Illness Therapy-fatigue
9%
Recovery Degree
9%
People with Lived Experience
9%
National Health Service Hospital
9%
Computerized Cognitive Assessment
9%
Generalized Anxiety Disorder 7-item Scale
9%
Prospective Longitudinal Cohort Study
9%
Medicine and Dentistry
Prospective Cohort Study
100%
COVID-19
100%
Neurodevelopmental Disorder
100%
Cognitive Decline
63%
Cognitive Defect
54%
Diseases
36%
Study Participant
18%
Odds Ratio
18%
National Health Service
9%
Mental Health
9%
Cohort Analysis
9%
Personal Experience
9%
Chronic Disease
9%
Biomedical Research
9%
C Reactive Protein
9%
Functional Assessment
9%
Severe Depression
9%
Patient Health Questionnaire
9%
Generalized Anxiety Disorder
9%
D-Dimer
9%
Cognitive Change
9%
Cognitive Assessment
9%
Nursing and Health Professions
Prospective Cohort Study
100%
COVID-19
100%
Mental Diseases
100%
Cognitive Defect
54%
Diseases
36%
Odds Ratio
18%
Study Participant
18%
Socialized Medicine
9%
Mental Health
9%
Syndrome
9%
Cohort Analysis
9%
Chronic Disease
9%
Functional Assessment
9%
C Reactive Protein
9%
Generalized Anxiety Disorder
9%
Patient Health Questionnaire
9%
Personal Experience
9%
D Dimer
9%
Neuroscience
Cognitive Disorders
100%
Subjective Cognitive Decline
100%
Psychopathology
100%
Generalized Anxiety Disorder
16%
C-Reactive Protein
16%
Severe Depression
16%
D Dimer
16%
Cognitive Change
16%
Cognitive Decline
16%
Psychology
COVID-19
100%
Psychopathology
100%
Cognitive Decline
63%
Cognitive Deficit
54%
Generalized Anxiety Disorder
9%
Chronic Disorder
9%
Lived Experience
9%
Functional Assessment
9%
Cognitive Assessment
9%
Severe Depression
9%
Cognitive Change
9%
Mental Health
9%